494 related articles for article (PubMed ID: 30791358)
1. Superparamagnetic Iron Oxide Nanoparticles-Current and Prospective Medical Applications.
Dulińska-Litewka J; Łazarczyk A; Hałubiec P; Szafrański O; Karnas K; Karewicz A
Materials (Basel); 2019 Feb; 12(4):. PubMed ID: 30791358
[TBL] [Abstract][Full Text] [Related]
2. Superparamagnetic iron oxide nanoparticles for delivery of therapeutic agents: opportunities and challenges.
Laurent S; Saei AA; Behzadi S; Panahifar A; Mahmoudi M
Expert Opin Drug Deliv; 2014 Sep; 11(9):1449-70. PubMed ID: 24870351
[TBL] [Abstract][Full Text] [Related]
3. New Frontiers in Molecular Imaging with Superparamagnetic Iron Oxide Nanoparticles (SPIONs): Efficacy, Toxicity, and Future Applications.
Frantellizzi V; Conte M; Pontico M; Pani A; Pani R; De Vincentis G
Nucl Med Mol Imaging; 2020 Apr; 54(2):65-80. PubMed ID: 32377258
[TBL] [Abstract][Full Text] [Related]
4. Hydroxyapatite as a Vehicle for the Selective Effect of Superparamagnetic Iron Oxide Nanoparticles against Human Glioblastoma Cells.
Pernal S; Wu VM; Uskoković V
ACS Appl Mater Interfaces; 2017 Nov; 9(45):39283-39302. PubMed ID: 29058880
[TBL] [Abstract][Full Text] [Related]
5. Targeted extracellular vesicle delivery systems employing superparamagnetic iron oxide nanoparticles.
Zhuo Z; Wang J; Luo Y; Zeng R; Zhang C; Zhou W; Guo K; Wu H; Sha W; Chen H
Acta Biomater; 2021 Oct; 134():13-31. PubMed ID: 34284151
[TBL] [Abstract][Full Text] [Related]
6. External magnetic fields affect the biological impacts of superparamagnetic iron nanoparticles.
Shanehsazzadeh S; Lahooti A; Hajipour MJ; Ghavami M; Azhdarzadeh M
Colloids Surf B Biointerfaces; 2015 Dec; 136():1107-12. PubMed ID: 26613856
[TBL] [Abstract][Full Text] [Related]
7. Recent Progress in Iron Oxide Nanoparticles as Therapeutic Magnetic Agents for Cancer Treatment and Tissue Engineering.
Nabavinia M; Beltran-Huarac J
ACS Appl Bio Mater; 2020 Dec; 3(12):8172-8187. PubMed ID: 35019598
[TBL] [Abstract][Full Text] [Related]
8. Hyaluronic acid conjugated superparamagnetic iron oxide nanoparticle for cancer diagnosis and hyperthermia therapy.
Thomas RG; Moon MJ; Lee H; Sasikala AR; Kim CS; Park IK; Jeong YY
Carbohydr Polym; 2015 Oct; 131():439-46. PubMed ID: 26256205
[TBL] [Abstract][Full Text] [Related]
9. Selection of potential iron oxide nanoparticles for breast cancer treatment based on in vitro cytotoxicity and cellular uptake.
Poller JM; Zaloga J; Schreiber E; Unterweger H; Janko C; Radon P; Eberbeck D; Trahms L; Alexiou C; Friedrich RP
Int J Nanomedicine; 2017; 12():3207-3220. PubMed ID: 28458541
[TBL] [Abstract][Full Text] [Related]
10. Development of superparamagnetic iron oxide nanoparticles (SPIONS) for translation to clinical applications.
Lin MM; Kim DK; El Haj AJ; Dobson J
IEEE Trans Nanobioscience; 2008 Dec; 7(4):298-305. PubMed ID: 19203873
[TBL] [Abstract][Full Text] [Related]
11. Superparamagnetic iron oxide nanoparticles (SPIONs) as a multifunctional tool in various cancer therapies.
Musielak M; Piotrowski I; Suchorska WM
Rep Pract Oncol Radiother; 2019; 24(4):307-314. PubMed ID: 31193459
[TBL] [Abstract][Full Text] [Related]
12. Recent advances in superparamagnetic iron oxide nanoparticles (SPIONs) for in vitro and in vivo cancer nanotheranostics.
Kandasamy G; Maity D
Int J Pharm; 2015 Dec; 496(2):191-218. PubMed ID: 26520409
[TBL] [Abstract][Full Text] [Related]
13. Superparamagnetic Iron Oxide Nanoparticles Modified with Silica Layers as Potential Agents for Lung Cancer Treatment.
Reczyńska K; Marszałek M; Zarzycki A; Reczyński W; Kornaus K; Pamuła E; Chrzanowski W
Nanomaterials (Basel); 2020 May; 10(6):. PubMed ID: 32486431
[TBL] [Abstract][Full Text] [Related]
14. Development and use of iron oxide nanoparticles (Part 1): Synthesis of iron oxide nanoparticles for MRI.
Lodhia J; Mandarano G; Ferris Nj; Eu P; Cowell S
Biomed Imaging Interv J; 2010; 6(2):e12. PubMed ID: 21611034
[TBL] [Abstract][Full Text] [Related]
15. Polymeric Reactor for the Synthesis of Superparamagnetic-Thermal Treatment of Breast Cancer.
Alhasan AH; Fardous RS; Alsudir SA; Majrashi MA; Alghamdi WM; Alsharaeh EH; Almalik AM
Mol Pharm; 2019 Aug; 16(8):3577-3587. PubMed ID: 31291120
[TBL] [Abstract][Full Text] [Related]
16. Superparamagnetic Iron Oxide Nanoparticles for Immunotherapy of Cancers through Macrophages and Magnetic Hyperthermia.
Dias AMM; Courteau A; Bellaye PS; Kohli E; Oudot A; Doulain PE; Petitot C; Walker PM; Decréau R; Collin B
Pharmaceutics; 2022 Nov; 14(11):. PubMed ID: 36365207
[TBL] [Abstract][Full Text] [Related]
17. Superparamagnetic Iron Oxide Nanoparticles: Cytotoxicity, Metabolism, and Cellular Behavior in Biomedicine Applications.
Wei H; Hu Y; Wang J; Gao X; Qian X; Tang M
Int J Nanomedicine; 2021; 16():6097-6113. PubMed ID: 34511908
[TBL] [Abstract][Full Text] [Related]
18.
Gharibkandi NA; Żuk M; Muftuler FZB; Wawrowicz K; Żelechowska-Matysiak K; Bilewicz A
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982357
[TBL] [Abstract][Full Text] [Related]
19. Luteinizing hormone-releasing hormone targeted superparamagnetic gold nanoshells for a combination therapy of hyperthermia and controlled drug delivery.
Mohammad F; Al-Lohedan HA
Mater Sci Eng C Mater Biol Appl; 2017 Jul; 76():692-700. PubMed ID: 28482580
[TBL] [Abstract][Full Text] [Related]
20. Superparamagnetic iron oxide nanoparticles conjugated with folic acid for dual target-specific drug delivery and MRI in cancer theranostics.
Huang Y; Mao K; Zhang B; Zhao Y
Mater Sci Eng C Mater Biol Appl; 2017 Jan; 70(Pt 1):763-771. PubMed ID: 27770953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
